Physician profile
Vinson Albert Smith
NPI 1669477345
$2,371.90
in general payments reported to CMS, 2019-2025
10 companies · $13.61 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,289 · 2020: $164 · 2022: $857 · 2024: $48.78 · 2025: $13.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,074.65 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $852.42 | 2022-2025 | Zilretta |
| Depuy Synthes Sales INC. | $124.73 | 2020 | |
| Acumed LLC | $109.73 | 2019 | |
| Ermi LLC | $53.10 | 2019-2024 | |
| Trice Medical, INC. | $48.62 | 2019 | |
| Fidia Pharma USA INC. | $43.84 | 2020-2024 | Hymovis |
| Zimmer Biomet Holdings, INC. | $28.08 | 2020 | |
| Bioventus LLC | $18.77 | 2019 | |
| Upsher-Smith Laboratories LLC | $17.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinson Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.